Nevro (NVRO) Stock Forecast, Price Target & Predictions
NVRO Stock Forecast
Nevro stock forecast is as follows: an average price target of $32.72 (represents a 511.59% upside from NVRO’s last price of $5.35) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.
NVRO Price Target
NVRO Analyst Ratings
Nevro Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 15, 2024 | David Rescott | Robert W. Baird | $5.00 | $4.92 | 1.63% | -6.54% |
Aug 08, 2024 | Joanna Wuensch | Citigroup | $6.89 | $5.67 | 21.52% | 28.79% |
Aug 08, 2024 | Richard Newitter | Truist Financial | $5.50 | $5.08 | 8.27% | 2.80% |
Aug 07, 2024 | David Rescott | Robert W. Baird | $8.00 | $5.00 | 60.00% | 49.53% |
Aug 07, 2024 | Matthew Taylor | Jefferies | $7.00 | $4.83 | 44.93% | 30.84% |
Aug 07, 2024 | Adam Maeder | Piper Sandler | $7.00 | $8.69 | -19.45% | 30.84% |
Aug 07, 2024 | Nathan Treybeck | Wells Fargo | $5.50 | $8.69 | -36.71% | 2.80% |
Apr 11, 2024 | Anthony Petrone | Mizuho Securities | $16.00 | $13.28 | 20.48% | 199.07% |
Apr 08, 2024 | Nathan Treybeck | Wells Fargo | $14.00 | $13.29 | 5.34% | 161.68% |
Jun 06, 2023 | Suraj Kalia | Oppenheimer | $40.00 | $23.71 | 68.72% | 647.66% |
Nevro Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 7 | 9 |
Avg Price Target | $5.00 | $6.41 | $8.32 |
Last Closing Price | $5.35 | $5.35 | $5.35 |
Upside/Downside | -6.54% | 19.81% | 55.51% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 08, 2024 | Citigroup | Sell | Neutral | Upgrade |
Aug 08, 2024 | Wolfe Research | - | Peer Perform | Upgrade |
Aug 07, 2024 | Jefferies | Underperform | Underperform | Hold |
Aug 07, 2024 | Piper Sandler | Underweight | Underweight | Hold |
Aug 07, 2024 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
Aug 07, 2024 | JMP Securities | Perform | Market Perform | Downgrade |
Aug 07, 2024 | JMP Securities | - | Perform | Downgrade |
Jul 10, 2024 | Citigroup | Sell | Sell | Hold |
May 22, 2024 | Citigroup | Neutral | Sell | Downgrade |
Apr 03, 2024 | Citigroup | Neutral | Neutral | Hold |
Nevro Financial Forecast
Nevro Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $103.86M | $108.81M | $96.33M | $113.84M | $100.47M | $104.21M | $87.84M | $102.76M | $93.20M | $102.33M | $88.61M | $109.73M | $108.46M | $56.39M | $87.47M | $114.37M | $100.16M |
Avg Forecast | $137.69M | $119.66M | $123.90M | $109.49M | $109.82M | $97.28M | $104.51M | $99.02M | $103.31M | $93.09M | $107.11M | $97.90M | $112.26M | $95.87M | $108.19M | $95.08M | $113.42M | $99.22M | $104.34M | $86.19M | $100.26M | $91.59M | $102.32M | $85.26M | $107.92M | $104.00M | $37.86M | $88.06M | $111.80M | $92.27M |
High Forecast | $137.69M | $119.66M | $123.90M | $109.49M | $109.82M | $97.28M | $104.51M | $99.02M | $103.31M | $93.97M | $107.11M | $97.90M | $112.33M | $104.57M | $108.19M | $95.08M | $113.42M | $99.22M | $104.34M | $86.19M | $100.26M | $91.59M | $102.32M | $85.26M | $107.92M | $104.00M | $37.86M | $88.06M | $111.80M | $92.27M |
Low Forecast | $137.69M | $119.66M | $123.90M | $109.49M | $109.82M | $97.28M | $104.51M | $99.02M | $103.31M | $92.00M | $107.11M | $97.90M | $112.05M | $94.58M | $108.19M | $95.08M | $113.42M | $99.22M | $104.34M | $86.19M | $100.26M | $91.59M | $102.32M | $85.26M | $107.92M | $104.00M | $37.86M | $88.06M | $111.80M | $92.27M |
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 4 | 5 | 4 | 4 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.01% | 1.01% | 1.00% | 1.01% | 1.00% | 1.02% | 1.02% | 1.02% | 1.00% | 1.04% | 1.02% | 1.04% | 1.49% | 0.99% | 1.02% | 1.09% |
Nevro EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 4 | 5 | 4 | 4 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-25.56M | $-25.64M | $-36.32M | $-19.36M | $-18.75M | $-20.55M | $-30.04M | $-24.00M | $-44.13M | $-13.59M | $-20.68M | $1.69M | $-1.39M | $-32.87M | $-19.63M | $-8.41M | $-12.76M |
Avg Forecast | $-36.14M | $-31.40M | $-32.52M | $-28.73M | $-28.82M | $-25.53M | $-27.43M | $-25.99M | $-27.11M | $-24.43M | $-28.11M | $-40.31M | $-29.46M | $-25.16M | $-28.39M | $-36.65M | $-26.40M | $-26.04M | $-27.38M | $-33.31M | $-26.31M | $-24.04M | $-26.85M | $-20.44M | $-28.32M | $-27.29M | $-9.93M | $-23.80M | $-29.34M | $-24.22M |
High Forecast | $-36.14M | $-31.40M | $-32.52M | $-28.73M | $-28.82M | $-25.53M | $-27.43M | $-25.99M | $-27.11M | $-24.14M | $-28.11M | $-32.25M | $-29.41M | $-24.82M | $-28.39M | $-29.32M | $-21.12M | $-26.04M | $-27.38M | $-26.65M | $-26.31M | $-24.04M | $-26.85M | $-16.35M | $-28.32M | $-27.29M | $-9.93M | $-19.04M | $-29.34M | $-24.22M |
Low Forecast | $-36.14M | $-31.40M | $-32.52M | $-28.73M | $-28.82M | $-25.53M | $-27.43M | $-25.99M | $-27.11M | $-24.66M | $-28.11M | $-48.37M | $-29.48M | $-27.44M | $-28.39M | $-43.98M | $-31.68M | $-26.04M | $-27.38M | $-39.98M | $-26.31M | $-24.04M | $-26.85M | $-24.53M | $-28.32M | $-27.29M | $-9.93M | $-28.56M | $-29.34M | $-24.22M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.90% | 0.99% | 0.73% | 0.72% | 0.75% | 0.90% | 0.91% | 1.84% | 0.51% | 1.01% | -0.06% | 0.05% | 3.31% | 0.83% | 0.29% | 0.53% |
Nevro Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 4 | 5 | 4 | 4 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-23.48M | $-24.72M | $-35.03M | $-19.19M | $81.51M | $-24.99M | $-34.33M | $-30.13M | $-50.08M | $-21.59M | $-29.56M | $-7.13M | $-9.98M | $-41.06M | $-24.89M | $-13.74M | $-17.85M |
Avg Forecast | $-9.97M | $-14.41M | $-12.19M | $-20.32M | $-20.59M | $-26.23M | $-21.30M | $-29.84M | $-25.01M | $-30.09M | $-25.76M | $-46.06M | $-18.07M | $-28.40M | $-25.48M | $-41.88M | $-33.15M | $-8.29M | $-29.85M | $-38.07M | $-31.65M | $-32.21M | $-27.08M | $-29.21M | $-12.33M | $-21.70M | $-60.08M | $-30.17M | $-23.38M | $-31.41M |
High Forecast | $-9.97M | $-14.41M | $-12.19M | $-20.32M | $-20.59M | $-26.23M | $-21.30M | $-29.84M | $-25.01M | $-24.58M | $-25.76M | $-36.85M | $-15.18M | $-16.23M | $-25.48M | $-33.50M | $-26.52M | $-8.29M | $-29.85M | $-30.46M | $-31.65M | $-32.21M | $-27.08M | $-23.37M | $-12.33M | $-21.70M | $-60.08M | $-24.13M | $-23.38M | $-31.41M |
Low Forecast | $-9.97M | $-14.41M | $-12.19M | $-20.32M | $-20.59M | $-26.23M | $-21.30M | $-29.84M | $-25.01M | $-35.96M | $-25.76M | $-55.28M | $-20.96M | $-33.56M | $-25.48M | $-50.25M | $-39.78M | $-8.29M | $-29.85M | $-45.68M | $-31.65M | $-32.21M | $-27.08M | $-35.05M | $-12.33M | $-21.70M | $-60.08M | $-36.20M | $-23.38M | $-31.41M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.97% | 0.84% | 0.58% | -9.84% | 0.84% | 0.90% | 0.95% | 1.55% | 0.80% | 1.01% | 0.58% | 0.46% | 0.68% | 0.83% | 0.59% | 0.57% |
Nevro SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 4 | 5 | 4 | 4 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $81.15M | $86.76M | $86.19M | $80.65M | $78.19M | $83.97M | $79.33M | $82.64M | $79.52M | $73.88M | $73.27M | $67.07M | $68.51M | $60.17M | $71.40M | $76.01M | $72.91M |
Avg Forecast | $106.69M | $92.72M | $96.01M | $84.84M | $85.10M | $75.38M | $80.98M | $76.73M | $80.05M | $72.13M | $83.00M | $75.86M | $86.99M | $74.29M | $83.83M | $73.67M | $90.90M | $76.88M | $80.85M | $66.78M | $77.69M | $70.97M | $79.29M | $72.40M | $83.63M | $80.59M | $29.33M | $86.55M | $86.63M | $71.50M |
High Forecast | $106.69M | $92.72M | $96.01M | $84.84M | $85.10M | $75.38M | $80.98M | $76.73M | $80.05M | $72.81M | $83.00M | $75.86M | $87.04M | $81.03M | $83.83M | $73.67M | $109.08M | $76.88M | $80.85M | $66.78M | $77.69M | $70.97M | $79.29M | $86.88M | $83.63M | $80.59M | $29.33M | $103.86M | $86.63M | $71.50M |
Low Forecast | $106.69M | $92.72M | $96.01M | $84.84M | $85.10M | $75.38M | $80.98M | $76.73M | $80.05M | $71.29M | $83.00M | $75.86M | $86.83M | $73.28M | $83.83M | $73.67M | $72.72M | $76.88M | $80.85M | $66.78M | $77.69M | $70.97M | $79.29M | $57.92M | $83.63M | $80.59M | $29.33M | $69.24M | $86.63M | $71.50M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.03% | 1.17% | 0.89% | 1.02% | 1.04% | 1.19% | 1.06% | 1.12% | 0.93% | 1.01% | 0.80% | 0.85% | 2.05% | 0.83% | 0.88% | 1.02% |
Nevro EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 13 | 13 | 7 | 7 | 7 | 7 | 9 | 4 | 5 | 4 | 4 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.65 | $-0.69 | $-0.98 | $-0.54 | $2.30 | $-0.71 | $-0.98 | $-0.86 | $-1.44 | $-0.62 | $-0.85 | $-0.21 | $-0.29 | $-1.21 | $-0.78 | $-0.44 | $-0.58 |
Avg Forecast | $-0.27 | $-0.39 | $-0.33 | $-0.55 | $-0.56 | $-0.71 | $-0.58 | $-0.81 | $-0.68 | $-0.81 | $-0.70 | $-1.05 | $-0.49 | $-0.77 | $-0.69 | $-1.05 | $-0.49 | $-0.22 | $-0.81 | $-1.10 | $-0.86 | $-0.87 | $-0.73 | $-0.85 | $-0.33 | $-0.59 | $-1.63 | $-0.99 | $-0.63 | $-0.85 |
High Forecast | $-0.27 | $-0.39 | $-0.33 | $-0.55 | $-0.56 | $-0.71 | $-0.58 | $-0.81 | $-0.68 | $-0.67 | $-0.70 | $-1.05 | $-0.41 | $-0.44 | $-0.69 | $-1.05 | $-0.49 | $-0.22 | $-0.81 | $-1.10 | $-0.86 | $-0.87 | $-0.73 | $-0.85 | $-0.33 | $-0.59 | $-1.63 | $-0.99 | $-0.63 | $-0.85 |
Low Forecast | $-0.27 | $-0.39 | $-0.33 | $-0.55 | $-0.56 | $-0.71 | $-0.58 | $-0.81 | $-0.68 | $-0.97 | $-0.70 | $-1.05 | $-0.57 | $-0.91 | $-0.69 | $-1.05 | $-0.49 | $-0.22 | $-0.81 | $-1.10 | $-0.86 | $-0.87 | $-0.73 | $-0.85 | $-0.33 | $-0.59 | $-1.63 | $-0.99 | $-0.63 | $-0.85 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 1.00% | 0.93% | 1.11% | -10.25% | 0.88% | 0.89% | 1.00% | 1.65% | 0.85% | 1.00% | 0.63% | 0.49% | 0.74% | 0.79% | 0.70% | 0.68% |
Nevro Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
NVRO | Nevro | $5.35 | $32.72 | 511.59% | Hold |
SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
FNA | Paragon 28 | $6.06 | $11.50 | 89.77% | Buy |
OFIX | Orthofix Medical | $17.33 | $31.00 | 78.88% | - |
LUNG | Pulmonx | $7.12 | $11.93 | 67.56% | Buy |
LIVN | LivaNova | $49.01 | $70.50 | 43.85% | Buy |
KIDS | OrthoPediatrics | $28.74 | $39.60 | 37.79% | Buy |
RXST | RxSight | $51.25 | $70.11 | 36.80% | Buy |
CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
IRMD | IRadimed | $49.36 | $60.00 | 21.56% | Buy |
ITGR | Integer | $126.53 | $138.00 | 9.07% | Buy |
CVRX | CVRx | $15.05 | $16.33 | 8.50% | Buy |
SRDX | Surmodics | $37.57 | $39.50 | 5.14% | Buy |
GKOS | Glaukos | $131.38 | $119.33 | -9.17% | Buy |
NVRO Forecast FAQ
Is Nevro a good buy?
No, according to 18 Wall Street analysts, Nevro (NVRO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 38.89% of NVRO's total ratings.
What is NVRO's price target?
Nevro (NVRO) average price target is $32.72 with a range of $5 to $125, implying a 511.59% from its last price of $5.35. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nevro stock go up soon?
According to Wall Street analysts' prediction for NVRO stock, the company can go up by 511.59% (from the last price of $5.35 to the average price target of $32.72), up by 2236.45% based on the highest stock price target, and down by -6.54% based on the lowest stock price target.
Can Nevro stock reach $8?
NVRO's average twelve months analyst stock price target of $32.72 supports the claim that Nevro can reach $8 in the near future.
What is Nevro's current price target trend?
1 Wall Street analyst forecast a $5 price target for Nevro (NVRO) this month, down -6.54% from its last price of $5.35. Compared to the last 3 and 12 months, the average price target increased by 19.81% and increased by 55.51%, respectively.
What are Nevro's analysts' financial forecasts?
Nevro's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $410.64M (high $410.64M, low $410.64M), average EBITDA is $-108M (high $-108M, low $-108M), average net income is $-97.955M (high $-97.955M, low $-97.955M), average SG&A $318.19M (high $318.19M, low $318.19M), and average EPS is $-2.652 (high $-2.652, low $-2.652). NVRO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $490.74M (high $490.74M, low $490.74M), average EBITDA is $-129M (high $-129M, low $-129M), average net income is $-56.883M (high $-56.883M, low $-56.883M), average SG&A $380.26M (high $380.26M, low $380.26M), and average EPS is $-1.54 (high $-1.54, low $-1.54).
Did the NVRO's actual financial results beat the analysts' financial forecasts?
Based on Nevro's last annual report (Dec 2022), the company's revenue was $406.36M, beating the average analysts forecast of $403.17M by 0.79%. Apple's EBITDA was $-204M, beating the average prediction of $-113M by 80.17%. The company's net income was $3M, missing the average estimation of $-109M by -102.74%. Apple's SG&A was $322.14M, beating the average forecast of $315.42M by 2.13%. Lastly, the company's EPS was $0.08, missing the average prediction of $-2.621 by -103.05%. In terms of the last quarterly report (Sep 2023), Nevro's revenue was $103.86M, beating the average analysts' forecast of $95.87M by 8.34%. The company's EBITDA was $-25.559M, beating the average prediction of $-25.16M by 1.59%. Nevro's net income was $-23.479M, missing the average estimation of $-28.4M by -17.33%. The company's SG&A was $81.15M, beating the average forecast of $74.29M by 9.24%. Lastly, the company's EPS was $-0.65, missing the average prediction of $-0.769 by -15.46%